Trial Profile
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Interferon beta-1a; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 17 Mar 2008 New trial record.